InvestorsHub Logo
Followers 0
Posts 111
Boards Moderated 0
Alias Born 02/09/2017

Re: mean gene post# 27142

Saturday, 03/18/2017 11:48:17 AM

Saturday, March 18, 2017 11:48:17 AM

Post# of 30352
Well Mean Gene. Overall I would agree with what you just said except that experience with this company has taught me that things are never as advertised. I see where they reiterated the six month review expectancy during the formal remarks on the CC. I am sure that if Matt Beck will say the same.

I will give Bryce credit on this because I had already written this situation off as it was going to happen in this fashion ( meaning the six month review ). It is not a 100% fool proof situation. I reviewed their own 10K yesterday - again. I found no mention of a six month review anywhere in the document. It did however mention a 10 month review preceded by a 60 day wait period - in order to review if the NDA is acceptable. With a notation that often times the FDA takes even longer.

This information is vital to my investment plans. It should also be vital to anybody that still has shares. The longer the wait, the more money that is going to be needed. Remember also that they are keen on keeping the NASDAQ listing, so that means they have to stay above the $2.5 m shareholder equity.

Like other people have said, it's all about FDA approval of Vitaros. Yeah, that's the end game. The question that everybody should be asking themselves is how much money is it going to take to allow the company to be still standing when that happens. That from a cost standpoint. And what is it worth if it's approved ( two scenario's upon possible approval that do not command the same valuation - Allergan opt in or not ).

The problem with most of the people on this board is that they want to concentrate on the possible reward. What about the necessary costs? Hasn't anybody learned anything from past experiences with this same company? Somehow management is to execute in a flawless fashion - this time around. When experience has taught us that they don't.

I could make a list of current management's self imposed goals and show you just how many they have failed on over the years. But this time it has to be different. Why? Because there is nothing left if they don't execute?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News